Gene · 3913
NIH grants2,633
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,121 to 1,140 of 2,633
Download this page as JSON| Grant | Title | LAMB2 papers | Newest fiscal year |
|---|---|---|---|
| R01HL135093 | Therapeutic Mechanisms of Cardiac Progenitors in Ischemic Cardiomyopathy | 1 | 2020 |
| R01HL137204 | Extracellular matrix regulation of differentiation via modulation of ILK: application to 3D bioprinting of cardiac tissue | 1 | 2020 |
| R01HL137649 | Uterine Arterial Spontaneous Transient Outward Currents in Pregnancy | 1 | 2020 |
| R01HL138437 | Molecular Drivers of Vascular Stiffness and Metabolic Dysfunction in HIV-Induced Pulmonary Arterial Hypertension | 1 | 2020 |
| R01LM012736 | Heuristics to evaluate biomedical and genomic knowledge bases for validity | 1 | 2020 |
| R01MH110259 | Neuroimmune mechanisms of depression in adults with HIV infection | 1 | 2020 |
| R01NS079445 | Molecular and Genetic Analysis of Adhesion Gpcrs in Myelinating Glial Cell Development | 1 | 2020 |
| R01NS091027 | The role of dystroglycan in neural circuit development. | 1 | 2020 |
| R01NS092339 | Development and Malformations of the Dentate Gyrus | 1 | 2020 |
| R01NS097161 | Molecular Recognition Principles, Engineering and Function of Neural Wiring Receptors | 1 | 2020 |
| R01NS100464 | The prohibitin family and their function in myelination and axonal health | 1 | 2020 |
| R21AG066038 | Identification of factors essential for age-related neuronal health: insights into common mechanisms of neurodegeneration | 1 | 2020 |
| R21DA047527 | Investigating the Systems Genetics of the Patterns of Polysubstance Abuse and Addiction | 1 | 2020 |
| R21EY029874 | Role of Hhip signaling in parallel circuit formation | 1 | 2020 |
| R21EY030568 | Retinal inputs signal through astrocytes to recruit interneurons into visual thalamus | 1 | 2020 |
| R21HG011424 | Optical Genome Mapping (OGM) for Concurrent Genetic and Epigenetic Diagnosis of Inborn Disorders | 1 | 2020 |
| R21HL146250 | Extracellular Matrix-Derived Nanoparticles for Repairing Lung Injury | 1 | 2020 |
| R21MH119813 | Epitranscriptomic Control of Local Gene Expression in Neural Stem Cells | 1 | 2020 |
| R21NS103841 | Analyzing Cell-Cell Fusion in Glioblastoma Growth and Progression | 1 | 2020 |
| R21NS114549 | Combinatorial matrix-mimetic recombinant proteins as engineered nerve guidance conduits | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3913/grants?page=57